The mechanistic contribution of PD-L1/L2 and PD-1 signaling of the host’s tumor microenvironment (TME) (CAF and immune cells) in the context of the tumor cells is elusive in endometrial cancers. The gene discussed is PDCD1; the disease is endometrial cancer.